Decanoyl-RVKR-CMK (TFA)

Decanoyl-RVKR-CMK (DecRVKRcmk) TFA inhibits over-expressed gp160 processing and HIV-1 replication[1].

Product Specifications

CAS Number

[2098497-25-5]

Product Name Alternative

DecRVKRcmk (TFA)

UNSPSC

12352209

Target

HIV

Type

Peptides

Related Pathways

Anti-infection

Applications

COVID-19-anti-virus

Field of Research

Infection; Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/decanoyl-rvkr-cmk-tfa.html

Purity

98.04

Solubility

DMSO : 100 mg/mL (ultrasonic) |H2O : 4 mg/mL (ultrasonic)

Smiles

CCCCCCCCCC(N[C@@H](CCCNC(N)=N)C(N[C@@H](C(C)C)C(N[C@@H](CCCCN)C(N[C@H](C(CCl)=O)CCCNC(N)=N)=O)=O)=O)=O.OC(C(F)(F)F)=O

Molecular Formula

C36H67ClF3N11O7

Molecular Weight

858.43

References & Citations

[1]B Bahbouhi, et al. Inhibition of HIV-2 (ROD) replication in a lymphoblastoid cell line by the alpha1-antitrypsin Portland variant (alpha1-PDX) and the decRVKRcmk peptide: comparison with HIV-1 (LAI) . Microbes Infect. 2001 Nov;3 (13) :1073-84.|[2]Angelo L Garcia, et al. A prohormone convertase cleavage site within a predicted alpha-helix mediates sorting of the neuronal and endocrine polypeptide VGF into the regulated secretory pathway. J Biol Chem. 2005 Dec 16;280 (50) :41595-608.